aMoon Velocity invests in companies pursuing disruptive, cutting-edge technologies as early as venture formation through seed.
We don't define ourselves by vertical, need, or even geographical boundaries but searching for transformational solutions to healthier lives and accelerated paths for value creation and building world-leading companies.
We nurture close collaborations with major pharma, biotech, medtech, digital multi-nationals, leading wall street banks, and prominent payers and provider networks. We look at every opportunity through their eyes and pain points.
Velocity can take an idea from inception through to successful IPO or acquisition; we strive to see the whole road ahead and try to imagine every milestone along the way and ensure that we plan from the start for each company's success.
Harnessing aMoon's unique platform, Velocity brings to bear the deep expertise of its team members, as well as the fund's extensive global network of relationships.
A robust footprint at the epicenter of a relentless ecosystem of breakthrough science and disruptive innovation. As Israel is quickly becoming a leading player in the next wave of HealthTech, with as many life-science companies in its purview as the other top healthcare hubs worldwide (San Francisco, Boston, New York, Switzerland), aMoon Velocity has unparalleled access to the Israeli innovation ecosystem.